Abstract
ObjectivesTo evaluate the effectiveness and safety of novel oral anticoagulants (NOACs) compared with vitamin K antagonists (VKAs) among patients with non-valvular atrial fibrillation (NVAF), particularly those with chronic kidney disease...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have